Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-03-22

FDA Approved: HYFTOR — Original Application (Nobelpharma America, LLC)

View source ↗

Summary

FDA approved HYFTOR (sirolimus) under an original application from Nobelpharma America, expanding treatment options with a topical sirolimus product. It is indi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hyftor (sirolimus)

Snippet

ORIG AP for HYFTOR (SIROLIMUS)